<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>7(4)</volume><submitter>Gyoten T</submitter><pubmed_abstract>&lt;h4>Aims&lt;/h4>The aim of this study was to compare the outcomes of surgical mitral valve repair or replacement (sMVR) and percutaneous edge-to-edge repair using MitraClip (pMVR) in patients with severe left ventricular dysfunction affected by functional mitral regurgitation (FMR).&lt;h4>Methods and results&lt;/h4>We retrospectively identified 132 patients with left ventricular ejection fraction (LVEF) ≦ 30% submitted to sMVR (n = 47) or pMVR (n = 85) for FMR at our centre from January 2013 to December 2017. To adjust for baseline imbalances, we used a propensity score matching by age, logistic EuroSCORE, and left ventricular end-systolic volume. After being matched, MitraClip therapy showed lower perioperative mortality and rate of complications yet increased residual mitral regurgitation (MR) gr</pubmed_abstract><journal>ESC heart failure</journal><pagination>1781-1790</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7373891</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Outcome comparison of mitral valve surgery and MitraClip therapy in patients with severely reduced left ventricular dysfunction.</pubmed_title><pmcid>PMC7373891</pmcid><pubmed_authors>Rochor K</pubmed_authors><pubmed_authors>Just S</pubmed_authors><pubmed_authors>Fritzsche D</pubmed_authors><pubmed_authors>Gyoten T</pubmed_authors><pubmed_authors>Herwig V</pubmed_authors><pubmed_authors>Schenk S</pubmed_authors><pubmed_authors>Harnath A</pubmed_authors><pubmed_authors>Messroghli D</pubmed_authors><pubmed_authors>Grimmig O</pubmed_authors></additional><is_claimable>false</is_claimable><name>Outcome comparison of mitral valve surgery and MitraClip therapy in patients with severely reduced left ventricular dysfunction.</name><description>&lt;h4>Aims&lt;/h4>The aim of this study was to compare the outcomes of surgical mitral valve repair or replacement (sMVR) and percutaneous edge-to-edge repair using MitraClip (pMVR) in patients with severe left ventricular dysfunction affected by functional mitral regurgitation (FMR).&lt;h4>Methods and results&lt;/h4>We retrospectively identified 132 patients with left ventricular ejection fraction (LVEF) ≦ 30% submitted to sMVR (n = 47) or pMVR (n = 85) for FMR at our centre from January 2013 to December 2017. To adjust for baseline imbalances, we used a propensity score matching by age, logistic EuroSCORE, and left ventricular end-systolic volume. After being matched, MitraClip therapy showed lower perioperative mortality and rate of complications yet increased residual mitral regurgitation (MR) gr</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Aug</publication><modification>2025-04-19T11:35:29.912Z</modification><creation>2025-04-19T11:35:29.912Z</creation></dates><accession>S-EPMC7373891</accession><cross_references><pubmed>32445540</pubmed><doi>10.1002/ehf2.12741</doi></cross_references></HashMap>